Dr. Siegelin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
New York, NY 10032Phone+1 774-823-9187
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 2010 - 2013
- Goethe University Frankfurt Medical FacultyClass of 2005
Certifications & Licensure
- NY State Medical License 2013 - 2024
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- 126 citationsHeat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells.Jagadish C. Ghosh, Markus D. Siegelin, Takehiko Dohi, Dario C. Altieri
Cancer Research. 2010-11-15 - 88 citationsAdaptive Mitochondrial Reprogramming and Resistance to PI3K TherapyJagadish C. Ghosh, Markus D. Siegelin, Valentina Vaira, Alice Faversani, Michele Tavecchio
Journal of the National Cancer Institute. 2015-03-01 - 93 citationsInsulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.Konstanze Plaschke, Juergen Kopitz, Markus D. Siegelin, Reinhard Schliebs, Melita Salkovic-Petrisic
Journal of Alzheimer's Disease. 2010-01-01
Press Mentions
- Velocity Raises More Than $1.1 Million to End CancerNovember 28th, 2022
- Three Columbia Physicians Named to American Society for Clinical InvestigationFebruary 14th, 2022
- Clinical Cancer Research Article Describes Opportunity to Use Imipridones for Brain TumorsAugust 22nd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: